Pharma M&A is an absolute seller’s market: Alpesh Dalal of Lupin

Lupin Ltd, India's second largest drugmaker by market value, had been pursuing inorganic expansion during 2007-11, but had gone quiet on the mergers and acquisitions (M&A) front since then. Early last year, it revived its M&A-led growth strategy and since then has signed half a dozen deals. In July, it ......